Triumph Capital Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Triumph Capital Management’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,744	Closed	-$889K	–	212
2022 Q1	$889K	Sell	22,744 -5,685	-20%	-$221K	0.38%	63
2021 Q4	$1.3M	Buy	28,429 +6,295	+28%	+$301K	0.56%	40
2021 Q3	$1.05M	Buy	22,134 +409	+2%	+$19.1K	0.49%	47
2021 Q2	$930K	Buy	+21,725	New	+$984K	0.54%	44

Other funds holding FFTY

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Triumph Capital Management's FFTY Position: Q2 2022 in Review

Triumph Capital Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2022, closing a stake of 22,744 shares — an estimated $889K sold.

Triumph Capital Management first reported a position in FFTY in Q2 2021 and held it in 4 quarters. The position peaked at $1.3M in Q4 2021. 58 funds tracked by Wall St. Rank hold FFTY as of Q2 2022.

Triumph Capital Management reported no remaining CapForce IBD 50 ETF position as of Q2 2022 after selling out during the quarter.
Triumph Capital Management sold 22,744 CapForce IBD 50 ETF shares in Q2 2022, an estimated $889K.
Triumph Capital Management first reported a position in CapForce IBD 50 ETF in Q2 2021 and held it in 4 quarters.
Triumph Capital Management's CapForce IBD 50 ETF position peaked at $1.3M in Q4 2021.
58 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2022.

Based on Triumph Capital Management's 13F filing for Q2 2022, filed 2 Aug 2022.